News
HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading Siemens Healthineers AG (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting Align Technology (NASDAQ:ALGN), ...
The FDA’s head during the Biden administration, Dr. Robert Califf, repeatedly said that the agency’s current regulatory model, in which approved devices are generally not scrutinized again, doesn’t ...
Duytschaever M, Grimaldi M, De Potter T, et al. Safety, efficacy and PVI durability of a contact force-sensing large-tip focal pulsed field ablation catheter ...
StockStory.org on MSN3d
JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above ExpectationsMultinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion ...
Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to ...
The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...
Umvuzo Health celebrates 21 years with AI-powered wearables, DNA testing, and gut microbiome analytics—offering a bold new ...
For the first quarter of this year, J&J’s total sales of $21.9 billion were up 4.2% over the start of 2024, when accounting ...
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...
Consolidation in the spine medtech space has been a constant in recent years from large mergers to smaller company acquisitions. For spine surgeons the transforming landscape presents opportunities ...
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG ...
4d
Vietnam Investment Review on MSNVenus Medtech Reports 2024 Profit Surge on Innovation and Global ExpansionAdhering to the principles of evidence-based medicine, Venus Medtech has consistently conducted long-term follow-up studies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results